Á lódáil...
Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study
BACKGROUND: Treatment with tamoxifen or chemotherapy reduces the risk of contralateral breast cancer (CBC). However, it is uncertain how long the protection lasts and whether the protective effect is modified by patient, tumor, or treatment characteristics. METHODS: The population-based WECARE Study...
Na minha lista:
Foilsithe in: | Breast Cancer Res |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
BioMed Central
2016
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4940926/ https://ncbi.nlm.nih.gov/pubmed/27400983 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-016-0726-0 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|